MedTrace Logo

Suggamadex and Fast-track Cardiac Anesthesia in a Developing Country

NCT02704351 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2023-05-06

No results posted yet for this study

Summary

The purpose of this study is to retrospectively review our preliminary experience during a surgical trip to Tuxtla, Mexico, using suggamadex to reverse neuromuscular blockade following CPB and cardiac surgery for repair of CHD in infants and children.

Conditions

  • Suggamadex
  • Surgery for Congenital Heart Disease

Interventions

PROCEDURE

Surgery

Sugammadex to reverse neuromuscular blockade

Sponsors & Collaborators

  • Joseph D. Tobias

    lead OTHER

Eligibility

Min Age
0 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2016-08-31
Completion
2016-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02704351 on ClinicalTrials.gov